Bragar Eagel & Squire Urges Picard Investors to Contact Firm Before April 3rd

Law firm announces class action lawsuit against Picard Medical over alleged stock promotion scheme.

Mar. 15, 2026 at 11:24pm

Got story updates? Submit your updates here. ›

Bragar Eagel & Squire, P.C., a national stockholder rights law firm, has filed a class action lawsuit against Picard Medical, Inc. (NYSE:PMI) in the United States District Court for the Northern District of California San Jose Division. The lawsuit alleges that Picard failed to disclose to investors that the company was the subject of a fraudulent stock promotion scheme involving social media-based misinformation and impersonated financial professionals, as well as insider and/or affiliate dumping of shares during a price inflation campaign.

Why it matters

The lawsuit alleges that Picard's stock price abruptly crashed 70% on October 24, 2025, and has continued to decline since then, causing significant losses for investors. The case highlights concerns around stock promotion schemes and the need for transparency from public companies.

The details

According to the complaint, Picard failed to disclose to investors: (1) that the company was the subject of a fraudulent stock promotion scheme involving social media-based misinformation and impersonated financial professionals; (2) that insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign; and (3) that Picard's public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity driving the stock price.

  • Investors have until April 3, 2026 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • The class period covers September 2, 2025 through October 31, 2025.
  • On October 24, 2025, Picard's stock price abruptly crashed 70%, to $3.99 per share.

The players

Bragar Eagel & Squire, P.C.

A nationally recognized stockholder rights law firm with offices in New York, South Carolina, and California.

Brandon Walker

Litigation Partner at Bragar Eagel & Squire, P.C.

Melissa Fortunato

Partner at Bragar Eagel & Squire, P.C.

Picard Medical, Inc.

A publicly traded medical device company.

Got photos? Submit your photos here. ›

What they’re saying

“If you purchased or acquired Picard securities between September 2, 2025, and October 31, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato directly at (212) 355-4648.”

— Brandon Walker, Litigation Partner, Bragar Eagel & Squire, P.C.

What’s next

Investors have until April 3, 2026 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The takeaway

This case highlights concerns around stock promotion schemes and the need for public companies to be transparent about factors that may be artificially inflating their stock price. Investors who suffered losses may have legal recourse through the class action lawsuit.